Results 201 to 210 of about 337,411 (342)

Patient‐Reported Outcomes with Selpercatinib Among Patients with RET Fusion–Positive Non‐Small Cell Lung Cancer in the Phase I/II LIBRETTO‐001 Trial

The Oncologist, EarlyView., 2021
Abstract Background LIBRETTO‐001 is an ongoing, global, open‐label, phase I/II study of selpercatinib in patients with advanced or metastatic solid tumors. We report interim patient‐reported outcomes in patients with RET fusion–positive non‐small cell lung cancer (NSCLC).
Anna Minchom, Aaron C. Tan, Erminia Massarelli, Vivek Subbiah, Valentina Boni, Bruce Robinson, Lori J. Wirth, Lisa M. Hess, Min‐Hua Jen, Jennifer Kherani, Elizabeth Olek, Caroline E. McCoach   +11 more
wiley   +1 more source

Occult constipation in children: An unaddressed problem of our day-to-day practice. [PDF]

World J Clin Pediatr
Benzamin MD, Chowdhury MZR, Chakroborty P, Ahmed A, Tamal TB, Deb T, Karim AB.   +6 more
europepmc   +1 more source

Recovery from symptoms using an extensively hydrolyzed formula with synbiotic in infants with presumed cow's milk allergy

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objective Extensively hydrolyzed formulas (eHF) are the first‐line approach for cow's milk protein allergy (CMPA). This study evaluated the effects of eHF with synbiotic eHF (SeHF) on the general condition and symptoms of presumed CMPA infants during the initial 4‐week exclusion diet period.
Anaïs Lemoine, Florence Villard‐Truc, Imene Ait Mohamed Amar, François Payot   +3 more
wiley   +1 more source

Patient‐Reported Outcomes with Selpercatinib Treatment Among Patients with RET‐Mutant Medullary Thyroid Cancer in the Phase I/II LIBRETTO‐001 Trial

The Oncologist, EarlyView., 2021
Abstract Background Medullary thyroid cancer (MTC) standard of care includes multikinase inhibitors (MKIs), which can exacerbate disease‐related diarrhea, primarily because of non‐RET kinase inhibition. We report diarrhea and other patient‐reported outcomes (PROs) with selpercatinib, a highly selective RET inhibitor, among patients with RET‐mutant MTC ...
Lori J. Wirth, Bruce Robinson, Valentina Boni, Daniel S.W. Tan, Caroline McCoach, Erminia Massarelli, Lisa M. Hess, Min‐Hua Jen, Jennifer Kherani, Elizabeth Olek, Vivek Subbiah   +10 more
wiley   +1 more source

Mobile app improves treatment of functional constipation in children: a randomized single-blind study. [PDF]

BMC Pediatr
Leszkowicz J, Nazar W, Wysokińska-Zakrzewska K, Zdun-Ryżewska A, Czadek-Asner P, Dettlaff-Dunowska M, Plata-Nazar K, Szlagatys-Sidorkiewicz A.   +7 more
europepmc   +1 more source

Evaluation of Patient-Driven Constipation Action Plans for Patients Discharged From a Pediatric Hospitalist Service

Zoltán Kiss, Andrew Allison, Melissa Knopp   +2 more
openalex   +2 more sources

Abdominal compartment syndrome secondary to chronic constipation in MECP2 duplication syndrome

, 2021
Alyaa Al Ali, Ram Singh, Guido Filler, Musaab Ramsi   +3 more
openalex   +2 more sources

The cost of constipation [PDF]

The Lancet Gastroenterology & Hepatology, 2019
openaire   +2 more sources

Chronic constipation [PDF]

Postgraduate Medical Journal, 1994
L, Kreel, M A, al-Kutoubi
openaire   +2 more sources

Toxic megacolon: A rare presentation and novel treatment

JPGN Reports, EarlyView.
Abstract A 14‐year‐old male presented with toxic megacolon (TM). Stool culture and rectal biopsies ruled out Clostridium difficile infection and Hirschsprung disease, respectively. Anorectal manometry ruled out anal achalasia as rectoanal inhibitory reflex elicited a normal resting pressure.
Adrienne P. Davis, Jennifer M. Schuh, Janice Bitong, Amy J. Wagner   +3 more
wiley   +1 more source